Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03380819 · ClinicalTrials.gov registry record · NA
The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care
A NA study, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03380819 is a NA study that has completed, run by VA Boston Healthcare System. The registered enrollment target is 2 participants.
The verdict
NCT03380819, a NA study, has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The VetSeq Study is a pilot intervention study exploring the feasibility of integrating genome sequencing into clinical care at the VA Boston Healthcare System.
Interventions
- DIAGNOSTIC_TEST Genome sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-12-29 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03380819
The ClinicalTrials.gov registry entry for NCT03380819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Boston Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genome sequencing is the first listed.
NCT03380819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03380819 about?
NCT03380819 is a clinical study titled "The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care". The VetSeq Study is a pilot intervention study exploring the feasibility of integrating genome sequencing into clinical care at the VA Boston Healthcare System.
What is the current status of trial NCT03380819?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-12-29. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03380819?
The interventions under investigation include: Genome sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03380819?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.